Scientists are developing a smartphone app that they say can accurately detect Down syndrome in infants soon after birth. Down syndrome, a genetic disorder that affects about 1-in-1,000 children worldwide, causes physical and intellectual disabilities. Early detection is beneficial to the development of children with the disorder, but that requires sophisticated medical tests not available everywhere. In developed countries, Down syndrome is often detected during prenatal screenings. But in less-developed countries, these tests are often not available. Marius Linguraru, a principal investigator at Washington’s Sheikh Zayed Institute for Pediatric Surgical Innovation, said genetic defects can be hard to diagnose after a baby is born.
Want the latest Children’s National news and stories as they happen? Sign up to get our News & Events releases by email.
Gulf News featured students from the UAE who came to Children's National for a summer of learning in the Sheikh Zayed Institute for Pediatric Surgical Innovation, as part of the 'Student Innovators Program.'
A preclinical study led by researchers at Children’s National Medical Center has found that a new oral drug shows early promise for the treatment of Duchenne muscular dystrophy (DMD).
Yuan Zhu, PhD, has joined Children’s National as Scientific Director and The Gilbert Family Professor of Neurofibromatosis Research for the Gilbert Family Neurofibromatosis Institute.
Catherine M. Bollard, MD, was appointed senior scientist in the Center for Cancer and Immunology Research and Co-Director of the Immunology Initiative of the Sheikh Zayed Institute.